Skip to main content

Main menu

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology

User menu

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow Kidney360 on Twitter
  • Community Forum
  • Kidney360 RSS
Original Investigation

The Integration of Diabetic Eye Screening into Haemodialysis Units in Northern Ireland

Laura N. Cushley, Nicola B. Quinn, Peter Blows, Edward McKeever and Tunde Peto
Kidney360 May 2022, 10.34067/KID.0001802022; DOI: https://doi.org/10.34067/KID.0001802022
Laura N. Cushley
1Centre for Public Health, Queen's University Belfast, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura N. Cushley
  • For correspondence: lcushley01@qub.ac.uk
Nicola B. Quinn
1Centre for Public Health, Queen's University Belfast, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Blows
2Queen's University Belfast, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward McKeever
3Diabetes & Endocrinology, South Eastern Health and Social Care Trust, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tunde Peto
2Queen's University Belfast, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Key Points

  • Previous literature shows people with type 2 diabetes and chronic kidney disease are more likely to have sight threatening retinopathy

  • Our study shows that many people attending for dialysis often fail to attend their annual diabetic eye screening appointments

  • High levels of sight threatening diabetic retinopathy were found in people on dialysis, showing the importance of screening in these clinics

Abstract

Background: Diabetes is rising globally and is the most common cause of both end-stage renal disease and blindness. People on haemodialysis have to attend several dialysis appointments per week which can affect their attendance at diabetic eye screening. In addition, previous literature suggests patients on haemodialysis are more likely to have sight threatening diabetic eye disease. This study aims to determine attendance at the Diabetic Eye Screening Programme in Northern Ireland, diabetic retinopathy severity and use of handheld retinal imaging in people with diabetes attending haemodialysis units in Northern Ireland. Methods: All patients with diabetes attending haemodialysis clinics regionally were screened and graded by the Diabetic Eye Screening Programme in Northern Ireland using a handheld and/or conventional non-mydriatic fundus camera. Results: All eligible 149 people were offered a Diabetic Eye Screening Programme in Northern Ireland appointment, 132 attended, 33.8% of whom have not been seen in >3 years and 15% had never attended Diabetic Eye Screening Programme in Northern Ireland despite multiple previous appointments. Altogether, 12.9% required urgent referral to hospital eye services which is significantly higher than the national average of 0.4%. Conclusions: Those on haemodialysis are at high risk for sight threatening diabetic retinopathy, implementing Diabetic Eye Screening Programme in Northern Ireland in haemodialysis clinics enables timely diagnosis and referral.

  • haemodialysis
  • eye screening
  • diabetic retinopathy
  • diabetic eye disease
  • diabetes
  • Northern Ireland
  • nephrology
  • Received March 4, 2022.
  • Revision received May 17, 2022.
  • Accepted May 17, 2022.
  • Copyright © 2022 American Society of Nephrology
PreviousNext
Back to top

In this issue

Kidney360: 3 (5)
Kidney360
Vol. 3, Issue 5
26 May 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Download PDF
Sign up for Alerts
Email Article

Thank you for your interest in spreading the word on American Society of Nephrology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Integration of Diabetic Eye Screening into Haemodialysis Units in Northern Ireland
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diabetic Eye and Haemodialysis
Laura N. Cushley, Nicola B. Quinn, Peter Blows, Edward McKeever, Tunde Peto
Kidney360 May 2022, 10.34067/KID.0001802022; DOI: 10.34067/KID.0001802022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Diabetic Eye and Haemodialysis
Laura N. Cushley, Nicola B. Quinn, Peter Blows, Edward McKeever, Tunde Peto
Kidney360 May 2022, 10.34067/KID.0001802022; DOI: 10.34067/KID.0001802022
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Osteopontin in CKD
  • Dysnatremia, Mortality, COVID-19
  • Medical Specialty Survey of Undergraduates.
Show more Original Investigation

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Google Scholar

Keywords

  • haemodialysis
  • eye screening
  • diabetic retinopathy
  • diabetic eye disease
  • diabetes
  • Northern Ireland
  • Nephrology

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • Kidney360
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About Kidney360
  • Kidney360 Email Alerts
  • Kidney360 Podcasts
  • Kidney360 RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to JASN and CJASN

© 2022 American Society of Nephrology

Online ISSN - 2641-7650

Powered by HighWire